Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of ACC017-based antiretroviral therapy in treatment-experienced adults with HIV-1 and NNRTI resistance mutations
CTR20250437Phase 2Active
- Sponsor
- Aidi Pharma
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asuptegravir in Human immunodeficiency virus infection type 1, sponsored by Aidi Pharma. Started Mar 2025; status: active.
02
Drugs
asuptegravir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on CTR20250437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250437.